chartexchange

TIL
Instil Bio, Inc. Common Stock
stockNASDAQ

At CloseNov 17, 2026 3:59:27 PM EST
5.44USD-5.391%(-0.31)164,635
After-hoursNov 17, 2026 4:00:30 PM EST
5.40USD-0.735%(-0.04)
4.7100Bid6.2600Ask1.5500Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Dallas, TX, USA
Previous Close
$5.75
Beta
0.43
52-Week High
$14.54 2025-11-17
52-Week Low
$5.28 2026-11-16
SMA 50
$6.70
SMA 200
$7.65
Avg. Vol 10D
69,788
Avg. Vol 30D
62,100
Avg. Vol 90D
28,552
Relative Vol
2.64
3.66M
0.5600%
9,803
Dec 8, 2023 · 1-for-20 (reverse)
TIL Profile

instil bio is a cell therapy company developing tumor infiltrating lymphocytes (til) for the treatment of solid tumor cancers. til are a patient's own t cells harvested from the patient's tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. the company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and a first-in-human study of its next-generation engineered til. the company is led by world-class cell therapy experts and backed by premier global institutional investors. instil is located in the greater los angeles area with additional manufacturing and research facilities in manchester, uk.

TIL Performance
PeriodPriceDateChangeBeta
1W6.352026-11-10-15.75%1.471
1M5.912026-10-16-9.47%0.316
3M7.362026-08-17-27.31%0.427
6M8.132026-05-18-34.19%0.351
1Y12.772025-11-17-58.10%0.426
2Y24.872024-11-18-78.49%—
5Y429.802021-11-17-98.75%1.595
TIL Stock Summary

Instil Bio, Inc. Common Stock (NASDAQ:TIL) stock price today is $5.35, and today's volume is 164,243. TIL is down 6.957% today. The 30 day average volume is 62,100. TIL market cap is $36.28M with 6.78M shares outstanding.